 - anti-cancer treatments including cytotoxic chemotherapy, radiotherapy, hormonal therapy, biologic, immunotherapy or investigational drugs received within 14 days or 5 half-lives for targeted therapies whichever is shorter before first dose of study drug to be supplemented 